Stoke Therapeutics Inc buy Guggenheim
Start price
07.02.26
/
50%
€26.00
Target price
07.02.27
€50.81
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 07.02.27. The prediction end date can be changed by Guggenheim at any time.Performance without dividends (%)
| Name | 1w |
|---|---|
| Stoke Therapeutics Inc | - |
| iShares Core DAX® | 1.085% |
| iShares Nasdaq 100 | -1.665% |
| iShares Nikkei 225® | 3.863% |
| iShares S&P 500 | 0.111% |
Comments by Guggenheim for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics (NASDAQ:STOK) is now covered by analysts at Guggenheim. They set a "buy" rating and a $60.00 price target on the stock.
Ratings data for STOK provided by MarketBeat